(Q38190483)

English

Prognostic role of circulating tumor cells and disseminated tumor cells in patients with prostate cancer: a systematic review and meta-analysis

scientific article published on 22 February 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

0 references

1 reference

Europe PubMed Central

Prognostic role of circulating tumor cells and disseminated tumor cells in patients with prostate cancer: a systematic review and meta-analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

systematic review

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

object named as

Xuelei Ma

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

4

object named as

Fengtian Wang

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

author name string

Zhilan Xiao

2

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

Xiaojun Li

3

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

Jing Zhang

5

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

Rubai Zhou

6

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

Junbo Wang

7

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

Lei Liu

8

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

22 February 2014

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

5551-5560

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

https://scigraph.springernature.com/pub.10.1007/s13277-014-1731-5

0 references

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1731-5

21 January 2018

A history of prostate cancer treatment

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1731-5

21 January 2018

Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1731-5

21 January 2018

EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1731-5

21 January 2018

A pooled analysis of bone marrow micrometastasis in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1731-5

21 January 2018

Meta-analysis of the prognostic value of circulating tumor cells in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1731-5

21 January 2018

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1731-5

21 January 2018

Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1731-5

21 January 2018

Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1731-5

21 January 2018

Circulating tumor cells in patients with castration-resistant prostate cancer baseline values and correlation with prognostic factors.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1731-5

21 January 2018

Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1731-5

21 January 2018

Combined androgen blockade therapy can convert RT-PCR detection of prostate-specific antigen (PSA) and prostate-specific membrane antigen (PSMA) transcripts from positive to negative in the peripheral blood of patients with clinically localized pros

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1731-5

21 January 2018

Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1731-5

21 January 2018

Association of circulating tumor cells with tumor-related methylated DNA in patients with hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1731-5

21 January 2018

Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1731-5

21 January 2018

Circulating endothelial cells, circulating tumour cells, tissue factor, endothelin-1 and overall survival in prostate cancer patients treated with docetaxel

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1731-5

21 January 2018

Perioperative activation of disseminated tumor cells in bone marrow of patients with prostate cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1731-5

21 January 2018

Detection of circulating tumor cells in different stages of prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1731-5

21 January 2018

RT-PCR for PSA as a prognostic factor for patients with clinically localized prostate cancer treated with radiotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1731-5

21 January 2018

Practical methods for incorporating summary time-to-event data into meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1731-5

21 January 2018

Presence of circulating prostate cancer cells in African American males adversely affects survival

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1731-5

21 January 2018

Random-effects model for meta-analysis of clinical trials: an update

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1731-5

21 January 2018

Publication bias in clinical research

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1731-5

21 January 2018

Disseminated tumor cells in prostate cancer patients after radical prostatectomy and without evidence of disease predicts biochemical recurrence

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1731-5

21 January 2018

Circulating tumor cells in prostate cancer: a potential surrogate marker of survival

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1731-5

21 January 2018

Isolation of rare circulating tumour cells in cancer patients by microchip technology

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1731-5

21 January 2018

Circulating tumor cells and prognosis of patients with resectable colorectal liver metastases or widespread metastatic colorectal cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1731-5

21 January 2018

Detection, clinical relevance and specific biological properties of disseminating tumour cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1731-5

21 January 2018

Tumor cell dissemination: emerging biological insights from animal models and cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1731-5

21 January 2018

Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1731-5

21 January 2018

Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1731-5

21 January 2018

Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1731-5

21 January 2018

Presence of circulating prostate cells in the bone marrow of patients undergoing radical prostatectomy is predictive of disease-free survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/24563278

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostatic carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24563278

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/24563278

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate stem cell antigen mRNA in peripheral blood as a potential predictor of biochemical recurrence in high-risk prostate cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24563278

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating tumor cells predict survival in patients with metastatic prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24563278

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of circulating tumor cell count in patients with metastatic hormone-sensitive prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24563278

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reverse transcription-polymerase chain reaction detection of prostate-specific antigen, prostate-specific membrane antigen, and prostate stem cell antigen in one milliliter of peripheral blood: value for the staging of prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24563278

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative reverse transcriptase polymerase chain reaction for prostate specific antigen predicts treatment failure following radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24563278

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative blood reverse transcriptase-PCR assays for prostate-specific antigen and human glandular kallikrein for prediction of prostate cancer progression after radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24563278

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating Tumor Cell Analysis in Patients with Progressive Castration-Resistant Prostate Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24563278

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of disseminated tumor cells in bone marrow at diagnosis in patients with nonmetastatic prostate cancer treated by definitive radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24563278

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of circulating tumor cells in patients with hormone refractory prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24563278

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analysis of circulating tumor cells as a prognostic marker in lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24563278

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of circulating prostate derived cells in patients with prostate adenocarcinoma is an independent risk factor for tumor recurrence

1 reference

https://pubmed.ncbi.nlm.nih.gov/24563278

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate Cancer Detection in a Clinical Urological Practice by Ultrasonography, Digital Rectal Examination and Prostate Specific Antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/24563278

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical and molecular followup after radical retropubic prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24563278

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase-plasminogen-activator receptor expression in disseminated tumour cells in the bone marrow and peripheral blood of patients with clinically localized prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24563278

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S13277-014-1731-5

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38190483&oldid=2135968758"